This is not the most recent version of the article. View current version (18 JUN 2015)

Intervention Review

Drugs versus placebo for dysthymia

  1. Mauricio Silva de Lima1,*,
  2. Joanna Moncrieff2,
  3. Bernardo Soares3

Editorial Group: Cochrane Depression, Anxiety and Neurosis Group

Published Online: 20 APR 2005

Assessed as up-to-date: 17 FEB 2005

DOI: 10.1002/14651858.CD001130

How to Cite

Silva de Lima M, Moncrieff J, Soares B. Drugs versus placebo for dysthymia. Cochrane Database of Systematic Reviews 2005, Issue 2. Art. No.: CD001130. DOI: 10.1002/14651858.CD001130.

Author Information

  1. 1

    Eli Lilly & Co, Medical, Basingstoke, Hampshire, UK

  2. 2

    Warley Hospital, University College London, Essex, UK

  3. 3

    Brazilian Cochrane Centre, São Paulo, SP, Brazil

*Mauricio Silva de Lima, Medical, Eli Lilly & Co, Lilly House, Priestley Road, Basingstoke, Hampshire, RG24 9NL, UK.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 20 APR 2005


This is not the most recent version of the article. View current version (18 JUN 2015)

Options for accessing this content:

  • If you are a society or association member and require assistance with obtaining online access instructions please contact our Journal Customer Services team.
  • Login via other institutional login options
  • You can purchase online access to this Article for a 24-hour period (price varies by title)
    • If you already have a Wiley Online Library or Wiley InterScience user account: login above and proceed to purchase the article.
    • New Users: Please register, then proceed to purchase the article.

Login via OpenAthens


Search for your institution's name below to login via Shibboleth.

Please register to:

  • Save publications, articles and searches
  • Get email alerts
  • Get all the benefits mentioned below!

Register now >

Patient Access

Patients and/or caregivers may access this content for use in relation to their own personal healthcare or that of a family member only. Terms and conditions will apply.